New Advances in Systemic Lupus Erythematosus (SLE)

Dear Colleagues,

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by immune-mediated inflammation affecting multiple organs. Due to a wide range of clinical manifestations, early diagnosis remains challenging. Furthermore, no single biomarker is currently available to definitively establish the diagnosis, assess disease activity, or predict disease progression.

Although advances in disease control have led to improved survival over the years, patients with SLE continue to experience higher morbidity and mortality (standardized mortality ratio: 2.66). To improve the prognosis, novel and targeted therapies are actively being developed to minimize disease activity and organ damage, as well as enhance quality of life.

This Special Issue on “New Advances in Systemic Lupus Erythematosus (SLE)” is now open for submissions. We welcome your contributions focusing on recent progress in the diagnosis and treatment of SLE.

Prof. Dr. Chang-Hee Suh
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.